Literature DB >> 22421134

Antigen-specific antibody responses in B-1a and their relationship to natural immunity.

Yang Yang1, Eliver Eid Bou Ghosn, Leah E Cole, Tetyana V Obukhanych, Patricia Sadate-Ngatchou, Stefanie N Vogel, Leonard A Herzenberg, Leonore A Herzenberg.   

Abstract

B-1a cells are primarily thought of as natural antibody-producing cells. However, we now show that appropriate antigenic stimulation induces IgM and IgG B-1a antibody responses and long-lived T-independent antigen-specific B-1a memory that differs markedly from canonical B-2 humoral immunity. Thus, we show here that in the absence of inflammation, priming with glycolipid (FtL) from Francisella tularensis live vaccine strain induces splenic FtL-specific B-1a to mount dominant IgM and activation-induced cytidine deaminase-dependent IgG anti-FtL responses that occur within 3-5 d of FtL priming and fade within 1 wk to natural antibody levels that persist indefinitely in the absence of secondary FtL immunization. Equally surprising, FtL priming elicits long-term FtL-specific B-1a memory cells (IgM>>IgG) that migrate rapidly to the peritoneal cavity and persist there indefinitely, ready to respond to appropriately administrated secondary antigenic stimulation. Unlike B-2 responses, primary FtL-specific B-1a responses and establishment of persistent FtL-specific B-1a memory occur readily in the absence of adjuvants, IL-7, T cells, or germinal center support. However, in another marked departure from the mechanisms controlling B-2 memory responses, rechallenge with FtL in an inflammatory context is required to induce B-1a secondary antibody responses. These findings introduce previously unexplored vaccination strategies for pathogens that target the B-1a repertoire.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421134      PMCID: PMC3325670          DOI: 10.1073/pnas.1121631109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

Review 2.  Antigen-specific memory B cell development.

Authors:  Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 3.  Signaling in B cells via Toll-like receptors.

Authors:  Stanford L Peng
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

4.  Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.

Authors:  Leah E Cole; Karen L Elkins; Suzanne M Michalek; Nilofer Qureshi; Linda J Eaton; Prasad Rallabhandi; Natalia Cuesta; Stefanie N Vogel
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

5.  B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae.

Authors:  Karen M Haas; Jonathan C Poe; Douglas A Steeber; Thomas F Tedder
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

6.  B1b lymphocytes confer T cell-independent long-lasting immunity.

Authors:  Kishore R Alugupalli; John M Leong; Robert T Woodland; Masamichi Muramatsu; Tasuku Honjo; Rachel M Gerstein
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

7.  Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.

Authors:  Miriam Shapiro-Shelef; Kuo-I Lin; Louise J McHeyzer-Williams; Jerry Liao; Michael G McHeyzer-Williams; Kathryn Calame
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

Review 8.  Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.

Authors:  Jory R Baldridge; Patrick McGowan; Jay T Evans; Christopher Cluff; Sally Mossman; David Johnson; David Persing
Journal:  Expert Opin Biol Ther       Date:  2004-07       Impact factor: 4.388

Review 9.  Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.

Authors:  Jay T Evans; Christopher W Cluff; David A Johnson; Michael J Lacy; David H Persing; Jory R Baldridge
Journal:  Expert Rev Vaccines       Date:  2003-04       Impact factor: 5.217

10.  IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice.

Authors:  Laurent Knoops; Jamila Louahed; Jean-Christophe Renauld
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  30 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Antigen-specific memory in B-1a and its relationship to natural immunity.

Authors:  Yang Yang; Eliver Eid Bou Ghosn; Leah E Cole; Tetyana V Obukhanych; Patricia Sadate-Ngatchou; Stefanie N Vogel; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

3.  Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Authors:  Patrick M Meyer Sauteur; Adrianus C J M de Bruijn; Catarina Graça; Anne P Tio-Gillen; Silvia C Estevão; Theo Hoogenboezem; Rudi W Hendriks; Christoph Berger; Bart C Jacobs; Annemarie M C van Rossum; Ruth Huizinga; Wendy W J Unger
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 4.  Hematopoietic stem cell-independent hematopoiesis and the origins of innate-like B lymphocytes.

Authors:  Eliver Ghosn; Momoko Yoshimoto; Hiromitsu Nakauchi; Irving L Weissman; Leonore A Herzenberg
Journal:  Development       Date:  2019-08-01       Impact factor: 6.868

5.  Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Authors:  Katharina Richard; Barbara J Mann; Aiping Qin; Eileen M Barry; Robert K Ernst; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

Review 6.  Glycan Reactive Natural Antibodies and Viral Immunity.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Viral Immunol       Date:  2019-12-17       Impact factor: 2.257

7.  2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.

Authors:  Aditi Upadhye; Jeffrey M Sturek; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 8.311

8.  H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease.

Authors:  Bita Sahaf; Yang Yang; Sally Arai; Leonard A Herzenberg; Leonore A Herzenberg; David B Miklos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Authors:  Rama D Yammani; Karen M Haas
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

10.  Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults.

Authors:  Karen M Haas; Maria W Blevins; Kevin P High; Bing Pang; W Edward Swords; Rama D Yammani
Journal:  J Infect Dis       Date:  2013-08-20       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.